Home/Filings/4/0001437749-25-005851
4//SEC Filing

Wong Vivien 4

Accession 0001437749-25-005851

CIK 0000922247other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 11:45 AM ET

Size

4.9 KB

Accession

0001437749-25-005851

Insider Transaction Report

Form 4
Period: 2025-02-27
Wong Vivien
Director
Transactions
  • Award

    Common Stock

    2025-02-27+25,14064,853 total
Footnotes (1)
  • [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2024 and from January 1, 2025 through March 25, 2025. The number of shares received in lieu of cash was calculated based on the closing price of $0.77 per share of common stock on February 26, 2025.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001638050

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 11:45 AM ET
Size
4.9 KB